ASBP
NASDAQ · Pharmaceuticals
Aspire Biopharma Holdings In
$0.15
-0.01 (-5.23%)
Open$0.13
Previous Close$0.16
Day High$0.17
Day Low$0.11
52W High$35.00
52W Low—
Volume—
Avg Volume44.89M
Market Cap778.7K
P/E Ratio—
EPS$-5.36
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 21.7K | 2.20M | 2.09M |
| Net Income | -86,809,519 | 266.8K | 312.0K |
| Profit Margin | -394,852.4% | 12.1% | 14.9% |
| EBITDA | -69,911,041 | 501.0K | 520.7K |
| Free Cash Flow | — | 197.3K | 259.9K |
| Rev Growth | — | +5.7% | +22.2% |
| Debt/Equity | 0.00 | 0.42 | 0.41 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |